Michael Gelband’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-120,618
Closed -$4.49M 1736
2026
Q1
$4.49M Buy
120,618
+83,965
+229% +$3.46M 0.04% 475
2025
Q4
$1.71M Buy
+36,653
New +$1.59M 0.01% 821
2025
Q2
Sell
-133,337
Closed -$6.72M 1630
2025
Q1
$6.72M Sell
133,337
-44,334
-25% -$2.2M 0.07% 320
2024
Q4
$7.63M Buy
177,671
+27,044
+18% +$1.14M 0.05% 336
2024
Q3
$5.91M Buy
150,627
+68,015
+82% +$2.46M 0.04% 364
2024
Q2
$2.66M Sell
82,612
-58,951
-42% -$1.9M 0.02% 676
2024
Q1
$4.67M Sell
141,563
-69,044
-33% -$2.4M 0.04% 411
2023
Q4
$7.31M Buy
+210,607
New +$7.26M 0.05% 266
2022
Q3
Sell
-70,455
Closed -$2.98M 2028
2022
Q2
$2.98M Buy
70,455
+65,317
+1,271% +$2.77M 0.04% 612
2022
Q1
$224K Buy
+5,138
New +$238K ﹤0.01% 1865
2021
Q4
Sell
-54,177
Closed -$2.57M 2315
2021
Q3
$2.57M Buy
54,177
+48,586
+869% +$2.41M 0.03% 626
2021
Q2
$254K Buy
+5,591
New +$253K ﹤0.01% 1837
2021
Q1
Sell
-118,400
Closed -$4.9M 2272
2020
Q4
$4.9M Buy
118,400
+63,788
+117% +$2.52M 0.05% 257
2020
Q3
$2.13M Buy
54,612
+32,904
+152% +$1.3M 0.04% 382
2020
Q2
$793K Buy
+21,708
New +$734K 0.02% 857
2019
Q4
Sell
-6,300
Closed -$244K 1660
2019
Q3
$244K Buy
+6,300
New +$250K 0.01% 1009

Other funds holding G

Michael Gelband's G Position: Q2 2026 in Review

Michael Gelband sold out of Genpact (G) in Q2 2026, closing a stake of 120,618 shares — an estimated $4.49M sold.

Michael Gelband first reported a position in G in Q3 2019 and held it in 16 quarters. The position peaked at $7.63M in Q4 2024. 475 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • Michael Gelband reported no remaining Genpact position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 120,618 Genpact shares in Q2 2026, an estimated $4.49M.
  • Michael Gelband first reported a position in Genpact in Q3 2019 and held it in 16 quarters.
  • Michael Gelband's Genpact position peaked at $7.63M in Q4 2024.
  • 475 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.